The need to define "who" rather than "if" for ECMO in COVID-19
- PMID: 35579687
- PMCID: PMC9112247
- DOI: 10.1007/s00134-022-06732-y
The need to define "who" rather than "if" for ECMO in COVID-19
Conflict of interest statement
This study received no direct funding. JZ receives funding from the Wellcome Trust (203928/Z/16/Z) and acknowledges support from the National Institute for Health Research (NIHR) Biomedical Research Centre based at Imperial College NHS Trust and Imperial College London. The other authors have no financial or non-financial competing interests to declare.
Comment on
-
Survival benefit of extracorporeal membrane oxygenation in severe COVID-19: a multi-centre-matched cohort study.Intensive Care Med. 2022 Apr;48(4):467-478. doi: 10.1007/s00134-022-06645-w. Epub 2022 Mar 3. Intensive Care Med. 2022. PMID: 35238946 Free PMC article.
-
Survival benefit of extracorporeal membrane oxygenation in severe COVID-19: "perceived futility" and potential underestimation of ECMO's effect.Intensive Care Med. 2022 Jul;48(7):977-978. doi: 10.1007/s00134-022-06711-3. Epub 2022 Apr 22. Intensive Care Med. 2022. PMID: 35459969 Free PMC article. No abstract available.
-
Where is the imperceptible difference?Intensive Care Med. 2022 Jul;48(7):975-976. doi: 10.1007/s00134-022-06710-4. Epub 2022 Apr 26. Intensive Care Med. 2022. PMID: 35474484 Free PMC article. No abstract available.
References
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
